Sana Biotechnology, Inc.

Healthcare

NASDAQ:SANA · NASDAQ Global Select

Market Cap $876.62M Beta 2.16 P/E (TTM) -3.5

$3.15 +1.23%

+$0.04 today

52W Low $2.58High $6.55

Vol 4.71M · Avg 3.76M

EPS (TTM) -$0.87Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+21.15%

Period High

$5.92

Period Low

$2.60

Latest

$3.15

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Dianthus Therapeutics, Inc.

NASDAQ:DNTH

$3.38B

Relay Therapeutics, Inc.

NASDAQ:RLAY

$2.81B

Kodiak Sciences Inc.

NASDAQ:KOD

$1.87B

Syndax Pharmaceuticals, Inc.

NASDAQ:SNDX

$1.70B

Nurix Therapeutics, Inc.

NASDAQ:NRIX

$1.48B

Inhibrx Biosciences, Inc.

NASDAQ:INBX

$1.35B

Nektar Therapeutics

NASDAQ:NKTR

$1.16B

Xencor, Inc.

NASDAQ:XNCR

$937.75M

Phathom Pharmaceuticals, Inc.

NASDAQ:PHAT

$855.60M

Oculis Holding AG

NASDAQ:OCS

$628.29M

What is the latest SANA filing?

The latest filing shown is 4 dated Jun 5, 2026.

How many recent filings does SANA have?

Intrinsic Alpha currently shows 20 recent filings for SANA.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.